Aligned Genetics Inc (238120) — Cash Flow Reinvestment Rate
Aligned Genetics Inc (238120) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting ₩265.20 Million (capex ₩165.20 Million plus investments ₩100.00 Million) from operating cash flow of ₩677.20 Million. Explore Aligned Genetics Inc (238120) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aligned Genetics Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Aligned Genetics Inc across 6 annual periods. Also explore Aligned Genetics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Aligned Genetics Inc (2019–2024)
Year-by-year capital reinvestment analysis for Aligned Genetics Inc. For live market cap and broader valuation context, see how much is Aligned Genetics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.57x | ₩7.89 Billion | ₩3.07 Billion | ₩340.06 Million | ▲ +237.6% |
| 2023 | 0.76x | ₩2.17 Billion | ₩2.85 Billion | ₩880.42 Million | ▼ -71.8% |
| 2022 | 2.70x | ₩6.00 Billion | ₩2.22 Billion | ₩2.00 Billion | ▼ -89.7% |
| 2021 | 26.15x | ₩3.56 Billion | ₩135.97 Million | ₩3.31 Billion | ▲ +17.1% |
| 2020 | 22.33x | ₩796.38 Million | ₩35.67 Million | ₩96.43 Million | ▲ +655.8% |
| 2019 | 2.95x | ₩1.95 Billion | ₩659.29 Million | ₩261.62 Million | — |